Клинико-генетическая характеристика спонтанных внутримозговых кровоизлияний в Республике Саха (Якутия)
Диссертация
Поиск ассоциации с ВМК в большинстве исследований проводили по небольшому числу полиморфных участков генов-кандидатовкроме того, при изучении генетической предрасположенности в группу исследования часто включали разные клинические формы геморрагических острых нарушений мозгового кровообращения, без учета этиологических и патогенетических факторов. Однако в последнее время пришло понимание, что… Читать ещё >
Список литературы
- Алексеев В. П. Особенности развития атеросклероза и ИБС, их патоморфоз у коренного и пришлого населения Крайнего Севера: эпидемиол. и патологоанатом, исслед.: дис.. д-ра мед. наук. М., 1990. 464 с.
- Афифи А., Эйзен С. Статистический анализ: подход с использованием ЭВМ. М.: Мир, 1982. 488 с.
- Виленский Б.С. Инсульт: профилактика, диагностика и лечение. 2-е изд., доп. СПб.: ФОЛИАНТ, 2002. 397 с.
- Виноградова Т.Е. Эпидемиология и хирургическая профилактика ишемического инсульта: дис.. д-ра мед. наук. Новосибирск, 2006. 387 с.
- Вклад генетических факторов в развитие артериальной гипертонии при разных типах инсульта у якутов / О. О. Фаворова и др. // Кардиол. вестн. 2007. Т. 2, № 1.С. 22−26.
- Геморрагический инсульт. Практическое руководство /Под ред. В. И. Скворцовой, В. В. Крылова. М.: ГЭОТАР-Медиа, 2005. 160 с.
- Генетические маркеры сердечно-сосудистых заболеваний / Е. С. Кылбанова и др. // Якутск, мед. журн. 2003. № 4. С. 63 65.
- Гланц С. Медико-биологическая статистика- пер. с англ. М.: Практика, 1999. 459 с.
- Дэвис С. Роль снижения артериального давления во вторичной профилактике инсульта // Журн. неврологии и психиатрии им. С. С. Корсакова. 2003. № 9. С. 82 84.
- Иллариошкин С. Н., Иванова-Смоленская И. А., Маркова Е. Д. ДНК-диагностика и медико-генетическое консультирование в неврологии. М.: МИА, 2002. С. 443−448.
- Инсульт. Практическое руководство для ведения больных- пер. с англ. /Ч. П. Ворлоу и др.- под ред. А. А. Скоромца, В. А. Сорокоумова. СПб.: Политехника, 1998. 629 с.
- Инсульт. Принципы диагностики, лечения и профилактики / Под ред. Н. В. Верещагина, М. А. Пирадова, 3. А. Суслиной. М.: Интермедика, 2002. 208 с.
- Кендалл М., Стьюарт А. Статистические выводы и связи: пер. с англ. М.: Глав. ред. физ.-мат. лит., 1973. 899 с.
- Ковальчук В. В., Скоромец А. А. Инсульт: эпидемиология, факторы риска и организация медицинской помощи // Неврол. журн. 2006. № 6. С. 46 — 49.
- Лебедев В. В., Крылов В. В. Неотложная нейрохирургия: рук. для врачей. М.: Медицина, 2000. 568 с.
- Леонов В. П. Обработка экспериментальных данных на программируемых микрокалькуляторах. Томск: Изд-во ТГУ, 1990. 376 с.
- Мамлеева Ф. Р., Кылбанова Е. С., Березовикова И. П. Избыточный вес. Выявление и коррекция: метод, рек. / Под ред. Ю. П. Никитина. Новосибирск, 1998. 20 с.
- Международная статистическая классификация болезней и проблем, связанных со здоровьем, 10-го пересмотра (МКБ-10). М.: Медицина, 2003.
- Николаева Т. Я. Ишемический инсульт в Восточно-Сибирском регионе: эпидемиология, факторы риска, клинико-генетические и нейроиммунные механизмы:.автореф. дис.. д-ра мед. наук. М., 2006. 40 с.
- Особенности клинических проявлений острого и восстановительного периодов у больных разного пола с инсультами /Д. А. Евлоева и др. //Журн. неврологии и психиатрии им. С. С. Корсакова. 2002. № 6. С. 32 35.
- Патофизиологические механизмы геморрагического инсульта и пути дифференцированной терапии /Е. И. Гусев и др. // Журн. неврологии и психиатрии им. С. С. Корсакова. Инсульт: прил. к журн. 2007. Вып. 21. С. 10 — 15.
- Первичная профилактика церебрального инсульта. Ч. 1. /А. В. Преображенский и др. // Журн. неврологии и психиатрии им. С. С. Корсакова. 2002. № 6. С. 19−23.
- Петрова И. Р. Клинические и генетические особенности гипертонической болезни в якутской популяции. Якутск: Сахаполиграфиздат, 2005. 104 с.
- Пирадов М. А. Геморрагический инсульт: новые подходы к диагностике и лечению //Атмосфера. Нервные болезни. 2005. № 5. С. 17−19.
- Прушенова С. А. Эпидемиология цереброваскулярных заболеваний в Бурятии: автореф. дис. .канд. мед. наук. Иркутск, 2001. 21 с.
- Пузырев В. П., Степанов В. А. Патологическая анатомия генома человека. Новосибирск: Наука, 1997. 224 с.
- Снижение заболеваемости, смертности и инвалидности от инсультов в Российской Федерации: сб. метод, рек., программ, алгоритмов /Под ред. В. И. Скворцовой. М.: Литтерра, 2007. С. 137- 168.
- Спиральная и многослойная компьютерная томография: в 2 т.- пер. с англ. / М. Прокоп, М. Галански- под ред. А. В. Зубарева, Ш. Ш. Шотемора. М: МЕДпресс-информ, 2006. Т. 1. 413 с.
- Справочник по прикладной статистике: в 2 т.: пер. с англ. /Под ред. Э. Ллойда, У. Ледермана, Ю. Н. Тюрина. М.: Финансы и статистика, 1989. Т. 1. 510 с.- Т. 2. 1990. 526 с.
- Сравнительный генетический анализ различных форм низкорениновой артериальной гипертезии /Н.М. Чихладзе и др. //Молекулярная биология. 2008. Т. 42, № 4. С. 588−598.
- Структура цереброваскулярной патологии у населения г. Якутска и ее динамика за 20-летний период / В. А. Аргунов и др. //Тез. X Рос.-Японс. Междунар. мед. симп. 2003. С. 277.
- Третьякова Н. Н. Эпидемиология и этнические особенности инсульта в г. Якутске (по данным регистра): автореф. дис.. канд. мед. наук. М., 2006. 25 с.
- Тул Д. Ф. Сосудистые заболевания головного мозга: рук. для врачей- пер. с англ. / Под ред. Е. И. Гусева, А. Б. Гехт. 6-е изд. М.: ГЭОТАР-Медиа, 2007. 608 с.
- Федорова С. А. Генетические портреты народов Республики Саха (Якутия): анализ линий митохондриальной ДНК и Y-хромосомы. Якутск: Изд-во ЯНЦ СО РАН, 2008. 235 с.
- Фейгин В. JI. Эпидемиология и профилактика цереброваскулярных заболеваний в условиях Сибири: автореф. дис.. д-ра мед. наук. М., 1991. 60 с.
- Функциональный исход ишемического и геморрагического инсульта после реабилитации в условиях стационара (исследование методом парных сравнений) / С. Паолюци и др. // Stroke. Рос. изд. 2004. Вып. I. С. 26 — 34.
- Чазова И. Е. Артериальная гипертензия: состояние проблемы и принципы терапии // Лечение нервных болезней. 2003. № 3. С. 3 6.
- Шкалы, тесты и опросники в медицинской реабилитации: рук. для врачей и медицинских работников / Под ред. А. Н. Беловой, О. Н. Щепетовой. М.: Антидор, 2002. 440 с.
- A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans / A. V. Favorov et al. //Genetics. 2005. Vol. 171. P. 2113−2121.
- A Western Australian kindred with Dutch cerebral amyloid angiopathy / P. K. Panegyres et al. //J. Neurol. Sci. 2005. Vol. 239, N 1. P. 75−80.
- Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study / R. Fogelholm et al. // J. Neurol. Neurosurg. Psychiatry. 2005. Vol. 76. P. 349−353.
- Advances in the genetics of cerebrovascular disease and stroke / G. J. Hademenos et al. //J. Neurology. 2001. Vol. 56. P. 997−1008.
- Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population / Y. Kokubo et al. //Stroke. 2000. Vol. 31, N 6. P. 1299−1306.
- Age-related spontaneous intracerebral hematoma in a German community / H. Schutz et al. //Stroke. 1990. Vol. 21 P. 1412.
- Alberts M. J. Genetics of cerebrovascular disease // Stroke. 2004. Vol. 35, N 2. P. 342−344.
- Alberts M. J. Stroke genetics update // Stroke. 2003. Vol. 34, N 2. P. 342 344.
- Alcohol and hemorrhagic stroke: the Honolulu Heart Program / R. P. Donahue et al. // JAMA. 1986. Vol. 255. P. 2311.
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels /В. Rigat et al. // J. Clin. Invest. 1990. Vol. 86. P. 1343 1346.
- Analysis of risk factors, localization and 30-day prognosis of intracerebral hemorrhage / D. Smajlovich et al. //Bosn. J. Basic Med. Sci. 2008. Vol. 8, N 2. -P. 121−125.
- Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes /M.J. Zychma et al. //Nephrol. Dial. Transplant. 2000. Vol. 15. P. 1965−1970.
- Angiotensin I-converting enzyme and chymase gene polymorphisms -relationship to left ventricular mass in type 2 diabetes patients. / J. Gumprecht J. et al. //Med Sci Monit. 2002. Vol. 8(8). P. 603−606.
- Angiotensin -I converting enzyme genotype DD is a risk factor for coronary artery disease /N. Beohar et al. //J. Investing. Med. 1995. Vol. 43. P. 275 457.
- Angiotensin II AT 1 receptor blockade reserves pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats /Н. Ando et al. //Stroke. 2004. Vol. 35. P. 1726 1731.
- Ankle-brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program / R. D. Abbott et al. //J. Clin. Epidemiol. 2001. Vol. 54, N 10. P. 973 -978!
- Antyhypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials / F. Gueyffier et al. //Lancet. 1999. Vol. 353. P. 793 -796.
- APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI / M. Kim et al. //Neurology. 2005. Vol.65, N 9. P. 1474−1475.
- Apolipoprotein E and Carotid Artery Atherosclerosis/ the Rotterdam Study / A. J. C. Slooter et al. //Stroke. 2001. Vol. 32. P. 1947.
- Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations / L. Pawlikowska et al. // Neurosurgery. 2006. Vol. 58, N5. P. 838−843.
- Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study I A. H. Chowdhury et al. // J. Epidemiol. 2001. Vol. 11, N 3. P. 131−138.
- Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage /Н. C. O’Donnel et al. // New England Journal of Medicine. 2000. Vol. 342. P. 240−245.
- Apolipoprotein E genotype, atherosclerosis, and cognitive decline: The Rotterdam Study / A. J. Slooter et al. // J. Neural. Trasm. 1998. Vol. 53. P. 17 -29.
- Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions / G. W. Rebeck et al. // Neuron. 1993. Vol. 11. P. 575- 580.
- Apolipoprotein E polymorphism and stroke in a population from eastern Turkey / S. Duzenli et al. // J. Neurogenet. 2004. Vol. 18, N 1. P. 365 375.
- Apolipoprotein H gene polymorphisms and risk of primary cerebral hemorrhage in a Chinese population / J. Xia et al. // Cerebrovasc. Dis. 2004. Vol. 17, N 2−3. P. 197−203.
- Appelros P., Nydevik I., Viitanen M. Poor outcome after first-ever stroke: Predictors for Death, Dependency, and Reccurent Stroke Within the First Year // Stroke. 2003. Vol. 34. P. 122 126.
- Arboix A. Clinical study of 14 patients with pontine hemorrhage // Med. Clin. (Bare). 2008. Vol. 130, 9. P. 339 341.
- Arboix A., Rennie M. Clinical study of 28 patients with cerebellar hemorrhage. // Med. Clin. (Bare). 2009. Vol. 132, N 17. P. 665 668.
- Association between renin-angiotensin-aldosterone system genotypes and haplotypes and risk of ischemic stroke of atherosclerotic etiology / S. Saidi et al. // Acta Neurologica Scandinavica. 2009. Vol. 119, N 6. P. 356 363.
- Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds / R. Lemmens et al. // Stroke. 2007. Vol. 38, N 4. P. 1185−1188.
- Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage / D. Woo et al. // Stroke. 2005. Vol. 36, N 9. P. 1874−1879.
- Berciano J. From the genetics to the prevention of stroke // Rev. Neurol. 1999. Vol. 29, N9. P. 836−847.
- Beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients / Y. Liu et al. // Chin. Med. J. (Engl). 2002. Vol. 115, N 2. P. 214−216.
- Beta-fibrinogen gene polymorphism (C148~>T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study / H. Schmidt et al. //Artherioscler.Thromb. Vase. Biol. 1998. Vol. 18, N 3. P. 487 492.
- Beta-fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: the ECTIM Study /1. Behague et al. // Circulation. 1996. Vol. 93. P. 440 449.
- Bishop Т., Sham P. Analysis of multifactorial disease // BIOS Ltd. 2000. P. 345.
- Broderick J. P., William M. Feinberg Lecture: Stroke therapy in the year 2025. Burden, breakthroughs and barriers to progress // Stroke. 2004. Vol. 35. P. 205 -211.
- Bullido M. J., Valdivieso F. Apolipoprotein E gene promoter polymorphisms in Alzheimer’s disease // Microsc. Rec. Techn. 2000. Vol. 50. P. 261 267.
- C677T polymorphism of the methylenehydrofolate reductase gene and the risk of ischemic stroke in Polish subjects / I. Goracy et al. // Journal of Applied genetics. 2009. Vol. 50, N 1. P. 63 67.
- CADASIL syndrome in a large Turkish kindred caused by the K90C mutation in the Notch3 receptor / U. Utku et al. // Eur. J. Neurol. 2002. Vol. 9, N 1. P. 23 -28.
- Caicoya M., Corrales C., Rodriguez T. Family history and stroke: a community case-control study in Austrias, Spain // J. Epidemiol. Biostat. 1999. Vol. 4. P. 313 -320.
- Caudate hemorrhage / R. W. Stein et al. // Neurology. 1984. Vol. 34. P. 1549.
- Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups /С. Hajat et al. // Stroke. 2001. Vol. 32, N 1. P. 37 42.
- Chen J., Li Y., Zhou J. A study of relationship between oral contraceptives and gene polymorphism and types of stroke // Zhonghua Liu Xing Bing Xue Za Zhi.2001. Vol. 22, N 4. P. 273 276.
- Cheung R. Т., Zou L. Y. Use of the Original, Modified or New Intracerebral Henorrhage Score to Predict Mortality and Morbidity After Intracerebral Hemorrhage // Stroke. 2003. Vol. 43. P. 1717 1722.
- Christensen H., Boysen G. Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke // Eur. J. Neurol.2002. Vol. 9. P. 297−301.
- Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage / A. Slowik et al. // Cerebrovasc. Dis. 2005. Vol. 19, N 3. P. 165 170.
- Danser J., Shunkert H. Renin-angiotensin system gene polymorphisms: potential mechanisms for there association with cardiovascular diseases // Eur. J. Pharmacology. 2000. Vol. 410. P. 303−316.
- DD genotype of ACE gene is a risk factor for intracerebral hemorrhage / A. Slowik et al. //Neurology. 2004. Vol. 63, N 2. P. 359 361.
- Deeb S. S., Peng R. Structure of the human lipoprotein lipase gene //Biochemistry. 1989. Vol. 28. P. 4131.
- Del Zoppo G. J., Mori E. Hematological causes of intracerebral hemorrhage and there treatment // Neurosurgical Clinics of North America. 1992. Vol. 3. P. 637 — 658.
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction / F. Cambien et al. // Nature. 1992. Vol. 359. P. 641 -644.
- Deletion polymorphisms of the angiotensin I-converting enzyme is associated with increased risk for myocardial infarction and coronary artery disease / B. R. Winkelmann et al. //Ann. Intern. Med. 1996. Vol. 125, N 1. P. 19 25.
- Dichgans M., Hegele R.A. Update on the genetic of stroke and cerebrovascular disease 2008 // Stroke. 2009. Vol. 40, N.5. P. 289−291.
- Differences in intracerebral hemorrhage between Mexican Americans and non-Hispanic whites / D. B. Zahuranec et al. // Neurology. 2006. Vol. 66. P. 30 34.
- Diringer M. N., Edwards D. F., Zazulia A. R. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral htmorrage //Stroke. 1998. Vol. 29. P. 1352 1357.
- Doris P. A. Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis // Hypertension. 2002. Vol. 39. P. 323 -331.
- Early neurologic deterioration in intracerebral hemorrhage. Predictors and associated factors / R. Leira et al. // Neurology. 2004. N 63. P. 461 467.
- Eastern stroke and coronary heart disease collaborative research group. Blood pressure, cholesterol, and stroke in eastern Asia // Lancet. 1998. Vol. 352. P.1801−1807.
- Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage / M. O. McCarron et al. // Acta Neurol. Scand. 2003. Vol. 107, N2. P. 106−109.
- Effects of Perindopril-Based Blood Pressure-Lowering Regimen on the Risk of Recurrent Stroke Accoding to Stroke Subtype and Medical History. The PROGRESS Trial / N. Chapman et al. // Stroke. 2004. Vol. 35. P. 116−121.
- Elston R. C. Linkage and association // Genet. Epidemiol. 1998. N 15. P. 565 -576.
- Ethnic differences in fibrinogen levels: the role of environmental factors and the beta-fibrinogen gene / D. G. Cook et al. // Am. J. Epidemiol. 2001. Vol. 153, N 8. P. 799−806.
- Ethnic differences in risk factors for ischemic stroke. A European case-control study / C. Hajat et al. // Stroke. 2004. Vol. 35, N 7. P. 1562 1567.
- Ethnic differences in stroke incidence. The south London Stroke register / J. Stewart et al. // British Medical Journal. 1999. Vol. 318. P. 967 971.
- Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage / J. Corral et al. // Hematol. J. 2000. Vol. 1. P. 269 273.
- Familial aggregation of stroke and intracerebral hemorrhage / D. Woo et al. //Stroke. 2000. Vol. 31. P. 316.
- Familial clustering of intracerebral hemorrhage: A prospective study in North Carolina / M. J. Alberts et al. // Neuroepidemiology. 2002. Vol. 21. P. 18 21.
- Familial occurrence of moyamoya disease: a clinical study / H. J. Seol et al. //Childs Nerv. Syst. 2006. Vol. 22, N 9. P. 1143 1148.
- Family history as a risk factor for stroke in young women / H. Kim et al. // J. Prev. Med. 2004. Vol. 27, N 5. P. 391 396. [138]
- Family histoiy of stroke in stroke types and subtypes / P. Polychronopoulos et al.//J. Neurol. Sci. 2002. Vol. 195, N2. P. 117−122.
- Favorov A. V., Ochs M. F. MCMC method for identification of allelic patterns In Data with quantitatively describable phenotypic features // BGRS' 2002, Novosibirsk, Russia, July 14−20, 2002. Vol. 2. P. 47 50.
- Fisher С. M. Cerebral miliary aneurysms in hypertension // Am J. Pathol. 1972. Vol. 66. P. 313.
- Flossmann E., Schulz U. G., Rothwell P. M. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke // Stroke. 2004. Vol. 35, N 1. P. 212−227.
- Frecuency and allelic asosiation of common variants in the lipoprotein lipase gene in different ethnic group: the Wandsworth Heart and Stroke Study / S. Hall et al. //Genet. Epidemiol. 2000. Vol. 18, N 3. P. 203 216.
- Frey J. L., Jahnke H. K., Goslar P. W. Study of the propensity for hemorrhage in Hispanic Americans with stroke // J. Stroke Cerebrovasc. Dis. 2008. Vol. 17, N 2. P. 58−63.
- Frossard P.M., Malloy M.J., Lestringant G.G., Kane J.P. Haplotypes of the humen rennin gene associated with essential hypertension and stroke / P. M. Frossard et al. // J. Hum. Hypertens. 2001. Vol. 15, N 1. P. 49 55. [101]
- Gebel J. M., Roderick J. P. Intracerebral hemorrhage // Neurologic Clinics. 2000. Vol. 19. P. 419−438.
- Gender-related association between beta-fibrinogen genotype and plasma fibrinogen levels and linkage disequlibrium at the fibrinogen locus in Greenland Inuit / M. P. De Maat et al. // Arterioscler. Thromb. Vase. Biol. 1995. Vol. 15, N 7. P. 856−860.
- Gender-specific associations of the fibrinogen В beta 448 polymorphisms, fibrinogen levels, and acute cerebrovascular disease / A. M. Carter et al. //Aterosclerosis, Thrombosis and Vascular Biology. 1997. Vol. 17. P. 589 594.
- Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study / D. Woo et al. // Stroke. 2002. Vol. 33, N 5. P. 1190- 1196.
- Genetic Epidemiology of Intracerebral Hemorrhage / D. Woo et al. // J. Stroke Cerebrovasc. Dis. 2005. Vol. 14, N 6. P. 239 243.
- Genetic Factors for Ischemic and Hemorrhagic Stroke in Japanese Individuals / Y. Yamada et al. // Stroke. 2008. Vol. 39. P. 2211 2218.
- Genetic Factors in Neonatology Study Group. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g. / W. Gopel et al. // J. Pediatr. 2002. Vol. 140, N 6. P. 688 692.
- Genetic predisposition to stroke in relatives of hypertensives / M. Nicolaou et al. // Stroke. 2000. Vol. 31, N 2. P. 487 492.
- Genetic risk for ischemic and hemorrhagic stroke / Y. Yamada et al. //Arterioscler.Thromb. Vase. Biol. 2006. Vol. 26, N 8. P. 1920 1925.
- Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population / S. Nishiuma et al. //Blood Coagul. Fibrinolysis. 1998. Vol. 9. P. 373 379.
- Greenberg S. M. Cerebral amyloid angiopathy and vessel dysfunction //Cerebrovasc. Dis. 2002. 13 Suppl 2. P. 42 47.
- Guidelines for the management of spontaneous intracerebral hemorrhage in adults / J. Broderick et al. // Stroke. 2007. Vol. 38. P. 2001 2023.
- Haan J. Herediatiary cerebral amyloid angiopathies // Stroke: predisposing conditions / Ed. D. Leys. London: Remedica Publishing, 2002. P. 79−88.
- Haan J., Algra P. R., Roos R. A. Hereditary cerebral haemorrhage with amyloidosis-Dutch type: clinical and computed tomographic analysis of 24 cases //Archives of Neurology. 1990. Vol. 47. P. 649 653.
- Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation / W. S. Brooks et al. // Neurology. 2004. Vol. 63, N 9. P. 1613−1617.
- Hemorrhagic Stroke Project Investigators. Major risk factors for aneurismal subarachnoid hemorrhage in the young are modifiable / J. P. Broderick et al. //Stroke. 2003. Vol. 34. P. 1375 1381.
- Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy / A. M. Remes et al. // Neurology. 2004. Vol. 63, N 2. P. 234 240.
- Herzig M. C., van Nostrand W. E., Jucker M. Mechanism of cerebral betaamyloid angiopathy: murine and cellular models // Brain Pathol. 2006. Vol. 16. P. 40−54.
- Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality. Ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study / T. S. Olsen et al. // Stroke. 2007. Vol. 38, N 10. P. 2646−2651.
- Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaL //J. Lipid Res. 1990. Vol. 31. P.545−548.
- Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hemorrhage / D. A. Godoy et al. // Neurocrit. Care. 2008. Vol. 9, N 2. P. 217−229.
- Hypertensive putaminal hemorrhage / D. B. Hier et al. // Ann Neurol. 1977. N l.P. 152.
- Hypotension at presentation is an indicator of poor prognosis in acute intracerebral haemorrhage / N. Hosomi et al. // J. Рак. Med. Assoc. 2008.Vol. 58, N 7. P. 359−361.
- Iadecola C., Gorelick P. Hypertension, Angiotensin, and Stroke: beyond Blood Pressure // Stroke. 2004. Vol. 35. P. 348 350.
- II Genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm / A. Slowik et al. // Stroke. 2004. Vol. 35, N 7. P. 1594 1597.
- Imaging and clinical prognostic indicators for early hematoma enlargement after spontaneous intracerebral hemorrhage / N. Ji et al. // Neurol. Res. 2009. Vol. 31, N4. P. 362−366.
- Incidence and Occurrence of Total (First-Ever and Recurrent) Stroke / G. R. Williams et al. // Stroke. 1999. Vol. 30. P. 2523 2528.
- Incidence and risk factors for stroke in American Indians: the Strong Heart Study / Y. Zhang et al. // Circulation. 2008. Vol. 118, N 15. P. 1577 1584.
- Incidence of stroke in Shibata, Japan, 1976−1978 / H. Tanaka et al. // Stroke. 1981. Vol. 12.460−466.
- Incidence of Hemorrhagic Stroke in Black Caribbean, Black African, and White Populations. The Sought London Stroke Register, 1995−2004 /N. C. Smeeton et al. // Stroke. 2007. Vol. 38. P. 3133 3138.
- Intracerebral Hemorrhage Triggers Interleukin-6 and Interleukin-10 Relase in Blood / T. Dziedzic et al. // Stroke. 2002. Vol. 33. P. 2334 2335.
- Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? / G. Endler et al. // Br. J. Haematol. 2003. Vol. 120, N 2.P. 310−314.
- Japan Standard Stroke Registry Study Group. Predictors of intracerebral hemorrhage severity and its outcome in Japanese stroke patients / N. Hosomi et al. // Cerebrovasc. Dis. 2009. Vol. 27, N 1. P. 67−74. [124]
- Jellinger K. A., Lauda F., Attems J. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage // Eur. J. Neurol. 2007. Vol. 14, N8. P. 923 -928.
- Kubota M., Yamaura A., Ono J. Prevalence of risk factors for aneurismal subarachnoid haemorrhage: results of a Japanese multicentre case control study for stroke // Br. J. Neurosurg. 2001. Vol. 15, N 6. P. 474 478.
- Lack of association between angiotensin I-converting enzyme gene deletion polymorphism and cerebrovascular disease in Taiwanese / J. J. Lin et al. // J. Formos. Med. Assoc. 2000. Vol. 99, N 12. P. 895 901.
- Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphisms with renal function among Chinese patients with type II diabetes / T. Y. Wong et al. // Amer. J. Kidney Dis. 1999. Vol. 33, N6. P. 1064- 1070.
- Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population / T. Seifert et al. // Cerebrovasc. Dis. 2006. Vol. 21, N4. P. 266−270.
- Lack of Evidence for an Association Between Hemodynamic Variables and Hematoma Growth in Spontaneous Intracerebral Hemorrhage / E. C. Jauch et al. //Stroke. 2006. Vol. 37. P. 2061.
- Landau W.M. Is cholesterol a risk factor for stroke? // NO. Arch Neurol. 1999, Vol.56. P.1521−1524.
- Levy E., Jaskolski M., Grubb A. The role of cystatin С in cerebral amyloid angiopathy and stroke: cell biology and animal models // Brain Pathol. 2006. Vol. 16, N1. P. 60−70.
- Linderstrom E., Baysen G., Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study // Am J. Epidem. 1995. Vol. 142. P. 1279- 1290.
- Lipoprotein lipase gene polymorphism: association with myocardial infarction and lipoprotein levels, the ECTIM study / R. Jemaa et al. // J. Lip. Res. 1995. Vol. 36. P. 2141.
- Lobar brain hemorrhages and white matter changes: Clinical, radiological and laboratorial profiles / L. F. Maia et al. // Cerebrovasc. Dis. 2006. 22(2−3). P. 155 -161.
- Lobar intracerebral hematomas: clinical and CT analysis of 22 cases / C. S. Kase et al. // Neurology. 1982. Vol. 32. Р. 1146.
- LPL polimorphism predicts stroke risk in men / A. C. Morrison et al. //Genet. Epidemiol. 2002. Vol. 22, N 3. P. 233 242.
- Lys (173)Arg and -344T С variants of CYP11B2 in Japanese patients with low-renin hypertension / Komiya I et al. // Hypertension. 2000. Vol. 35(3). P. 699 703.
- Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology // Science. 1988. Vol. 240. P. 622−630.
- Mahley R. W., Nathan B. P., Pitas R. E. Apolipoprotein E: structure, function, and possible roles in Alzheimer’s diseases // Ann. NY Acad. Sci. 1996. Vol. 777. P. 139- 145.
- Majersik J. J., Skalabrin E. J. Single-gene stroke disorders // Semin. Neurol. 2006. Vol. 26, N1. P. 33−48.
- Management of Acute Stroke / Ed. A. Shuaib, L. B. Goldstein. New York: Marcel Dekker, 1999. P. 399 414.
- Markus H. S., Alberts M. J. Update on Genetics of Stroke and Cerebrovascular Disease 2005 // Stroke. 2006. Vol. 37. P. 288 290.
- Martinez-Gonzalez N. A., Sudlow C. L. Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage // J. Neurol. Neurosurg. Psychiatry. 2006. Vol. 77, N 12. P. 1329 1335.
- Mattson M. P. Advances fuel Alzheimer’s conundrum // Nat. Genet. 1997. Vol. 17. P. 254−256.
- McCarron M. O., Delong D., Alberts M. J. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis // Neurology. 1999. Vol. 53. P. 1308−1311.
- McCarron M. O., Nicoll J. A. R. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage // Annals of the New York Academy of Sciences. 2000. Vol. 903. P. 176 179.
- Meade T. W. Fibrinogen and other clotting factors in cardiovascular disease. Atherosclerotic cardiovascular disease, hemostasis and endothelial function /Ed. R. Francis. N.Y.: Marcel Dekker, 1992. P. 1−34.
- Measurements of acute cerebral infarction: a clinical examination scale / T. Brott et al. // Stroke. 1989. Vol. 20. P. 864 870.
- Meschia J. F., Brott T. G., Brown R. D. Genetics of cerebrovascular disorders //Mayo Clin. Proc. 2005. Vol. 80, N 1. P. 122 132.
- Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C / A. Sazci et al. // Brain Res. Bull. 2006. Vol. 71, N 1/3. P. 45 50.
- Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism / J. Frederiksen et al. // Blood. 2004. Vol. 15, N. 104(10). P. 3046−3051.
- Microbleeds in hereditary cerebral hemorrhage with amyloidosis-Dutch type / R. van den Boom et al. // Neurology. 2005. Vol. 64, N 7. P. 1288 1289.
- Molecular Cloning / J. Sambrook, E. F. Fritsch, T. Maniatis- ed C. Nolan. Cold Spring Harbor Press. 1989. P. 9.17−9.19.
- Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage / Y. Silva et al. // Stroke. 2005. Vol. 36. P. 86−91.
- Multicenter Case-Control Study in China. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a
- Multicenter Case-Control Study in China / Z. Li et al. // Stroke. 2003. Vol. 34, N 9. P. 2085−2090.
- Multivariate analysis of risk factors for stroke: eight-year follow-up of farming villages in Akita, Japan / H. Ueshima et al. // Prevent. Med. 1980. Vol. 9. P. 722.
- Nicoll J. A., McCaiTon M. О. APOE gene polymorphisms as a risk factor for cerebral amyloid angiopathy-related hemorrhage // Amyloid. 2001. Vol. 8. P. 51 -55.
- Niu Т., Chen X., Xy X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular diseases: therapeutic implications // Drugs. 2002. Vol. 62. P. 977−993.
- Ojemann R. G., Heros R. C. Spontaneous brain hemorrhage // Stroke. 1983. Vol. 14. P. 468−475.
- Orlacchio A., Bernardi G. Research actuality in the genetics of stroke // Clin. Exp. Hypertens. 2006. Vol. 28, N 3−4. P. 191 197.
- Ortel T. L. Genetics of coagulation disorders // Genetics of cerebrovascular disease / Ed. M. J. Alberts. New York: Futura Publishing Company, 1999. P. 129 156.
- Phosphodiesterase 4D gene polymorphism is associated with ischaemic and haemorrhagic stroke / H. Xue et al. // Clin. Sci. (Lond). 2009. Vol. 116. P. 335 -340.
- Poirier J., Sevigny P. Apolipoprotein E4, cholinergic integrity and the pharmocogenetics of Alzheimer’s disease // J. Neural. Trasm. 1998. Vol. 53. P. 199−207.
- Polymorphism of apoprotein E (APOE), ethylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease /Е. Topic et al. // Clin. Chem. Lab. med. 2001. Vol. 39, N 4. P. 346 350.
- Polymorphism of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women / A. P. Reiner et al. // Stroke. 2001. Vol. 32, N 11. P. 2580−2586.
- Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese / Y. Shimo-Nakanishi et al. // Stroke. 2002. Vol. 32, N7. P. 1481 1486.
- Polymorphisms in the coagulation factor VII gene and risk of primary intracerebral hemorrhage / S. Greisenegger et al. // Eur. J. Neurol. 2007. Vol. 14. P. 1098- 1101.
- Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage / J. Corral et al. // Blood. 2001. Vol. 97, N 10. P. 2979 2982.
- Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples / H. Iso et al. // Thromb. Haemost. 1995. Vol. 73, N l.P. 106−111.
- Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score / N. S. Rost et al. // Stroke. 2008. Vol. 39, N 8. P. 2304−2309.
- Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages / M. Castellanos et al. // J. Neurol. Neurosurg. Psychiatry. 2005. Vol. 76. P. 691−695.
- Predictors of outcome in warfarin-related intracerebral hemorrhage / A. Y. Zubkov et al. // Arch. Neurol. 2008. Vol. 65, N 10. P. 1320 1325.
- Prevalence and magnitude of classical risk factors for stroke in a cohort of 5092 Chinese steelworkers over 13,5 years of follow-up / X-F. Zhang et al. // Stroke. 2004. Vol. 35. P. 1052- 1056. .
- Proportion of Different Subtypes of Stroke in China / Zhang Lin-Feng et al. //Stroke. 2003. Vol. 34. P. 2091 2096.
- Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts // Lancet. 1995. Vol. 346. P. 1547- 1653.
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer’s diseases / E. H. Corder et al. // Nat. Genet. 1994. N 7. P. 180 184.
- Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study / R. L. Sacco et al. // Stroke. 2001. Vol. 32, N 8. P. 1725 1731.
- Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Determinants of intracerebral hemorrhage growth: an exploratory analysis / J. P. Broderick et al. // Stroke. 2007. Vol. 38. P. 1072 1075.
- Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension / K. Kohara et al. // Am J Cardiol. 1999. Vol. 83, N 3. P. 367−370.
- Relationship of angiotensin converting enzyme genotype with serum triglyceride concentration in stroke patients / T. del Ser et al. // Neurosc. Lett. 2001. Vol. 316. P. 21−24.
- Renin-Angiotensin system genetic polymorphism and soft sensitivity in essential hypertension / V. Giner et al. l // Hypertension. 2000. Vol. 35, N 2. P. 512−517.
- Risk factors for intracerebral hemorrhage in general population: a systematic review. / Ariesen M.J. et al. // Stroke. 2003. Vol. 34. P. 2060−2065.
- Risk of stroke in male cigarette smokers / R. D. Abbott et al. // N. Engl. J. Med. 1986. Vol. 315, N 12. P.717 720.
- Role of Blood Clot Formation in Early Edema Development After Experimental Intracerebral Hemorrhage / Y. Xi et al. // Stroke. 1998. Vol. 24. P. 2580 2586.
- Ropper A. H., Davis K. R. Lobar cerebral hemorrhages: acute clinical syndromes in 26 cases // Ann. Neurol. 1980. Vol. 8. P. 141.
- Rose G., Collwell L. Randomised controlled trial of antismoking advice: final (20 year) results // J. Epidemiol. Commun. Health. 1992. Vol. 46. P. 75 77.
- Ross O. A., Worrall В. В., Meschia J. F. Advancing stroke therapeutics through genetic understanding // Curr. Drug Targets. 2007. Vol. 8, N 7. P. 850−859.
- RostN. S., Greenberg S. M., Rosand J. The genetic architecture of intracerebral hemorrhage // Stroke. 2008. Vol. 39, N 7. P. 2166 2173.
- Sex Differences in Clinical Presentation, Resource Use, and 3-Month Outcome of Acute Stroke in Europe. Data from a Multicenter Multinational Hospital-Based Registry / A. D. Carlo et al. // Stroke. 2003. Vol. 34. P. 1114−1119.
- Seppo J., Hillbom M., Palomaki H. Risk factors for spontaneous intracerebral hemorrhage // Stroke. 1995. Vol. 26. P. 1558 1564.
- Sia S. F., Tan K. S., Waran V. Primary intracerebral haemorrhage in Malaysia: in-hospital mortality and outcome in patients from a hospital based registry // Med. J. Malaysia. 2007. Vol. 62, N 4. P. 308 312.
- Sing С. F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation // Am. J. Hum. Genet. 1985. Vol. 37. P. 268−285.
- Smith E. E., Greenberg S. M. (3-amyloid, blood vessels, and brain function //Stroke. 2009. Vol. 40, N 7. P. 2601 2606.
- Spontaneous intracerebral hemorrhage / A. I. Qureshi et al. // New England Journal of Medicine. 2000. Vol. 344. P. 1450 1460.
- Stamler J., Stamler R., Neaton J. D. Blood pressure, systolic and diastolic, and cardiovascular risk: US population data //Arch. Intern. Med. 1993. Vol. 153. P. 615−622.
- Starr J. M., Rush M., Dennis M. S. Parental causes of death in primary intracerebral haemorrhage // Cerebrovasc. Dis. 2001. Vol. 12, N 4. P. 313 317.
- Strittmatter W. J., Roses A. D. Apolipopronein E Alzheimer’s disease // Annu. Rev. Neurosci. 1996. Vol. 319. P. 53 77.
- Stroke genetics / Edited by Hugh Markus. First publish. New York: Oxford University Press Inc., 2003. 346 p.
- Stroke in Biracial Population: the Excess Burden of Stroke Among Blacks / B. Kissela et al. // Stroke. 2004. Vol. 35. P. 426 431.
- Stroke in the Young in the Northern Manhattan Stroke Study / B. S. Jacobs et al. // Stroke. 2002. Vol. 33, N 12. P. 2789 2793.
- Stroke syndromes / Ed. J. Bogousslavsky, L. Caplan. Second edition. New York: Cambridge University Press, 2001. 747 p.
- Stroke: Pathophysiology, Diagnosis and Management / Ed. H. J. M. Barnett, J. P. Mohr, В. M. Stein, F. M. Yatsu. Second Edition. New York: Churchill Livingstone, 1992. 1270 p.
- The -148G/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case controle study / P. M. G. van Goor et al. // J. Neurol. Neurosurg. Psych. 2005. Vol. 76. P. 121.
- The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults / G. Peck et al. // PLoS ONE. 2008. Vol. 3.P. 3691.
- The Harvard Cooperative Stroke Registry: a prospective registry / J. P. Mohr et al. //Neurology. 1978. Vol. 28. P. 754.
- The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: a preliminary study / L. T. Dunn et al. // Neurosurgery. 2001. Vol. 48, N 5. P. 1006 1010.
- The insertion-deletion polymorphism of the angiotensin converting ensime gene and cardiovascular risk / J. A. Staessen et al. // J. Hypertension. 1997. Vol. 15. P. 1579−1592.
- The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese / S. P. Zhao et al. // Clin. Chim. Acta. 2003. Vol. 330, N 1−2. P. 161 164.
- The relationship of apolipoprotein H G1025C (Try316Ser) polymorphism with stroke and its effect on plasma lipid levels in Changsha Hans / J. Xia et al. //Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003. Vol. 20, N 2. Р. 114 118.
- The relationship of apolipoprotein H gene polymorphism with stroke / J. Xia et al. // Zhonghua Yi Xue Za Zhi. 2003. Vol. 83, N 7. P. 537 540.
- Thomson G., Esposito M.S. The genetics of complex disease // T.I.G. 1999. Vol. 15 (millennium issue). M17-M20.
- Three-Year Survival and Stroke Recurrence Rates in Patients with Primary Intracerebral Hemorrhage / E. Zia et al. // Stroke. 2009. Vol. 40, N 11. P. 3567 -3573.
- Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke / J. Jannes et al. // Stroke. 2004. Vol. 35. P. 1090−1094.
- Trends in Stroke Incidence and Acute Case Fatality in a Japanese Rural Area. The Oyabe Study / Y. Morikawa et al. // Stroke. 2000. Vol. 31. P. 1583 1587.
- Trends in the Incidence, Mortality, and Survival Rate of Cardiovascular Disease in a Japanese Community. The Hisayama Study / M. Kubo et al. // Stroke. 2003. Vol. 34. P. 2349−2354.
- Trimble В., Wainwright K., Lanier A. Stroke in Yup’ik Eskimos // Neurology. 1999. Vol. 52. P. 313.
- Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration /
- F.M. van 4 Hooft et al. // Arterioscler. Thromb. Vase. Biol. 1999. Vol. 19(12). P.3063−3070.
- Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality / J. P. Broderick et al. // Stroke. 1993. Vol. 24. P. 987 993.
- Wade D. T. Measurement in neurological rehabilitation // New York: Oxford University Press, 1992.
- Wannamethee S.G., Shaper A.G. Patterns of alcohol intake and risk of stroke in middle-aged British men //Stroke. 1996. Vol.27. P. 1033−1039.
- Wannamethee S.G., Shaper A.G. Alcohol, coronary heart disease and stroke: an examination of the J-shaped curve // Neuroepidemiol. 1998. Vol. 17. P. 288−295.
- Waters R. J., Nicoll J. A. Genetic influences on outcome following acute neurological insults // Curr. Opin. Crit. Care. 2005. Vol. 11, N 2. P. 105 110.
- Werbrouck B. F., De Bleecker J. L. Intracerebral haemorrhage in CADASIL. A case report // Acta Neurol. Belg. 2006. Vol. 106/4, N 4. P. 219 221.
- What Determines Good Recovery in Patients with the most Severe Strokes? / H. S. Jorgensen et al. // Stroke. 1999. Vol. 30. P. 2008−2012.
- Xi G., Keep R. F., Hoff J. T. Mechanisms of brain injury after intracerebral haemorrhage //Lancet Neurol. 2006. Vol. 5, N 1. P. 53 63.
- Young W. L., Yang G. Y. Are there genetic influences on sporadic brain arteriovenous malformations? // Stroke. 2004. Vol. 35. P. 2740 2745.1. АНКЕТА
- ИССЛЕДОВАНИЯ ГЕМОРРАГИЧЕСКОГО ИНСУЛЬТА
- История болезни №Дата исследования1. Фамилия Имя Отчество2. Дата рождения/ возраст3. Пол3. Национальность4. Домашний адрес, телефон5. Семейное положение6. ДИАГНОЗ7. Дата заболевания
- АНАМНЕЗ: дата появления первых признаков цереброваскулярной недостаточности81 Сопутствующие заболевания
- Перенесенные операции, травмы, дата83 Для женщин
- Факторы риска (подчеркнуть, дата) Гипертония Диабет Курение Алкоголь Диета Ожирение Физическая активность Гипотиреоз Другие
- Дедушка, бабушка по материнской. линии
- Дедушка, бабушка по отцовской линии1. Сибсы пробанда10. Рост- Вес
- Артериальное давление сист/диаст.
- Число сердечных сокращений
- Тяжесть состояния при поступлении
- Динамика неврологического статуса по шкалам
- ПАРАКЛИНИЧЕСКИЕ МЕТОДЫ ИССЛЕДОВАНИЯ
- Общий анализ крови Э-, нв-, лейк-, п-, с-, э-, лимф-, мон-, СОЭ1. Общий холестерин1. Бета-липопротеидытриглицериды1. Креатинин мочевина1. Фибриноген1. Глюкоза, ммоль/л1. СРБ1. АСАТ АЛАТ1. Белок общ альбумин1. Билирубин норма1. ЭКГ
- УЗИ паренхиматозных органов Окулист Терапевт Эндокринолог АД 1- 23- 4- 56
- Методы нейровизуализации (описание)
- ИСХОД ЗАБОЛЕВАНИЯ (подчеркнуть.указать дату) Выписан (а)17. Степень восстановленияв регистре1. Диагноз
- ИНФОРМИРОВАННОЕ СОГЛАСИЕ НА ПРЕДОСТАВЛЕНИЕ ДНК1. В БАНК ДНК1. я, нижеподписавшийся (аяся)
- Подпись врача-лаборанта: Подпись врача-генетика: